GTx third quarter net loss increases to $9.3 million

[News]

GTx, Inc. today reported financial results for the third quarter of 2011. The net loss for the quarter ended September 30, 2011 was $9.3 million compared with a net loss of $8.6 million for the quarter ended September 30, 2010, reflecting increased research and development costs in connection with the Company's Ostarine™ and Capesaris™ clinical development programs.

More... (http://www.news-medical.net/news/20111104/GTx-third-quarter-net-loss-increases-to-2493-million.aspx)